ストックスクリーナーアプリを入手
123.89
0.67%
-0.245
Gilead Sciences Inc (GILD) 最新ニュース
Universal Beteiligungs und Servicegesellschaft mbH Lowers Position in Gilead Sciences, Inc. $GILD - MarketBeat
Migdal Insurance & Financial Holdings Ltd. Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
US Stocks Recap: What is the PEG ratio of Gilead Sciences IncPrice Action & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Gilead Sciences: Margin Expansion And Cash Flow Strength Underpriced (NASDAQ:GILD) - Seeking Alpha
The Truth About Gilead Sciences Inc: Why Everyone Is Suddenly Watching This Stock - AD HOC NEWS
Bernstein reiterates Outperform rating on Gilead stock with $135 price target - Investing.com
Gilead Sciences, Inc. $GILD Shares Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat
Royal Bank Of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
40 Under 40: Calvin Yan Ting Chan, Gilead Sciences - Medical Marketing and Media
Stocks Generating Improved Relative Strength: Gilead Sciences - Investor's Business Daily
Gilead Sciences Earnings Outlook: Key Points to Watch - Bitget
Lobbying Update: $30,000 of TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES INC. lobbying was just disclosed - Quiver Quantitative
Gilead Sciences Earnings Preview: What to Expect - Barchart.com
Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Allstate Corp Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (NASDAQ:GILD) Nasdaq Futures Spotlight Biopharma Scale - Kalkine Media
Csenge Advisory Group Has $2.38 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Campbell & CO Investment Adviser LLC Invests $1.40 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by QRG Capital Management Inc. - MarketBeat
HER2-Negative Metastatic Breast Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai - Barchart.com
Insider Sell: Andrew Dickinson Sells 3,000 Shares of Gilead Scie - GuruFocus
Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares of Stock - MarketBeat
Gilead Sciences CCO Mercier sells $372,930 in stock - Investing.com
Gilead Sciences CFO Dickinson sells $372,930 in stock - Investing.com India
The Truth About Gilead Sciences: Is This ‘Boring’ Pharma Stock About To Blow Up? - AD HOC NEWS
Hedge Fund Moves: Whats the analyst consensus on Gilead Sciences IncWeekly Profit Recap & Fast Gain Stock Tips - baoquankhu1.vn
Gilead: A Top GARP Biotech Play, But Momentum Weakens (Downgrade) (NASDAQ:GILD) - Seeking Alpha
Looking Into Gilead Sciences Inc's Recent Short Interest - Benzinga
Gilead Sciences, Inc. $GILD Shares Purchased by Ritholtz Wealth Management - MarketBeat
GILD Stock Price, Forecast & Analysis | GILEAD SCIENCES INC (NASDAQ:GILD) - Chartmill
Short Covering: Is GCTSWS stock a good pick for beginnersJuly 2025 Chart Watch & Expert Approved Trade Ideas - baoquankhu1.vn
Gilead stock holds Buy rating at UBS as Yeztugo launch shows promise - Investing.com
Gilead Sciences, Inc. $GILD Shares Sold by Conning Inc. - MarketBeat
JPM26: Gilead Captures Sunny JPM Mood With Yeztugo Numbers, HIV Vibes - BioSpace
Gilead Sciences, Inc. (GILD) Stock Analysis: Strong Buy Ratings and 10.84% Potential Upside - DirectorsTalk Interviews
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Manning & Napier Advisors LLC Has $13.65 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences CFO Andrew Dickinson sells $14 million in stock - MSN
A Look At Gilead Sciences (GILD) Valuation After JP Morgan Conference HIV Pipeline Update - Sahm
GILD: Morgan Stanley Lowers Price Target for Gilead Sciences | G - GuruFocus
Morgan Stanley Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - MarketBeat
Gilead Sciences stock rating reiterated at Outperform by BMO Capital - Investing.com
Nordea Investment Management AB Has $494.03 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by TD Private Client Wealth LLC - MarketBeat
Liberty One Investment Management LLC Increases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by PKO Investment Management Joint Stock Co - MarketBeat
Polaris Capital Management LLC Sells 12,500 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead price tries to regain footingForecast today13-01-2026 - Economies.com
Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs - GlobeNewswire Inc.
Gilead Sciences, Inc. (NASDAQ:GILD) Is a Favorite Amongst Institutional Investors Who Own 88% - 富途牛牛
Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing - sharewise.com
Gilead Expects FDA Decision on Anito-Cel in First Quarter of 2026 - Precision Medicine Online
Gilead Sciences: From All-Time Highs To Higher Highs (NASDAQ:GILD) - Seeking Alpha
Gilead’s new HIV prevention shot added to CVS’s drug coverage lists, CEO says - 104.1 WIKY
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says - Reuters
Gilead Sciences to Seek Bolt-On Value-Creating Acquisitions - marketscreener.com
Sumitomo Mitsui Trust Group Inc. Buys 27,232 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Meeder Asset Management Inc. Has $16.76 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Nexus Investment Management ULC Buys 21,220 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Tema Etfs LLC Buys 25,912 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Inside Gilead’s 2030 Strategy to Advance 10 Transformative Therapies - Endpoints News
9,809 Shares in Gilead Sciences, Inc. $GILD Bought by Elite Wealth Management Inc. - MarketBeat
First Horizon Corp Takes $8.02 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
UBS and Citi Go Bullish on Gilead Sciences (GILD) - Insider Monkey
The Bull Case For Gilead Sciences (GILD) Could Change Following New OncoNano Drug-Delivery Collaboration - Yahoo Finance
Is Gilead Sciences (GILD) Pricing Reflecting Recent 38.5% One Year Share Return? - Yahoo Finance
New York State Teachers Retirement System Has $121.45 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
0.07%
3.11%
大文字化:
|
ボリューム (24 時間):